1. Kynd Stress Relief recall in Australia

   News item 07 May 2022 Pages: 1 - 1

2. Recall of two lots of SyrSpen SF Cherry in USA

   Unknown 07 May 2022 Pages: 2 - 2

3. Systemic betamethasone may cause pheochromocytoma crisis

   News item 07 May 2022 Pages: 3 - 3

4. Barriers to ADR reporting by hospital staff

   Clinical study 07 May 2022 Pages: 4 - 4

5. Biopsy-proven 5-ASA induced interstitial nephritis

   Clinical study 07 May 2022 Pages: 5 - 5

6. Ceftriaxone associated with encephalopathy, risk factors identified

   Clinical study 07 May 2022 Pages: 6 - 6

7. Changes to paracetamol labels have no impact on accidental overdoses

   Clinical study 07 May 2022 Pages: 7 - 7

8. COVID-19 vaccination may reactivate varicella-zoster virus

   Clinical study 07 May 2022 Pages: 8 - 8

9. Ivermectin-associated SCARs

   Clinical study 07 May 2022 Pages: 9 - 9

10. Methotrexate-related cutaneous ulceration

    Clinical study 07 May 2022 Pages: 10 - 10

11. Oral corticosteroids increase risk of obesity in adults with asthma

    Clinical study 07 May 2022 Pages: 11 - 11

12. Serious adverse events with tofacitinib versus TNF inhibitors

    Clinical study 07 May 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 07 May 2022 Pages: 13 - 13

14. Acetylcholine

    Case report 07 May 2022 Pages: 14 - 14

15. Aciclovir/antibacterials/ketorolac

    Case report 07 May 2022 Pages: 15 - 15

16. Ad26.cov2-s/AZD-1222

    Case report 07 May 2022 Pages: 16 - 16

17. Ad26.cov2-s/tozinameran

    Case report 07 May 2022 Pages: 17 - 17

18. Adalimumab/golimumab/infliximab

    Case report 07 May 2022 Pages: 18 - 18

19. Adalimumab/methotrexate

    Case report 07 May 2022 Pages: 19 - 19

20. Afatinib

    Case report 07 May 2022 Pages: 20 - 20

21. Afatinib/osimertinib/pembrolizumab

    Case report 07 May 2022 Pages: 21 - 21

22. Aflibercept

    Case report 07 May 2022 Pages: 22 - 22

23. Albendazole

    Case report 07 May 2022 Pages: 23 - 23

24. Albendazole

    Case report 07 May 2022 Pages: 24 - 24

25. Alectinib

    Case report 07 May 2022 Pages: 25 - 25

26. Alectinib

    Case report 07 May 2022 Pages: 26 - 26

27. Alemtuzumab

    Case report 07 May 2022 Pages: 27 - 27

28. Alprazolam

    Case report 07 May 2022 Pages: 28 - 28

29. Alteplase

    Case report 07 May 2022 Pages: 29 - 29

30. Amikacin/ethambutol/isoniazid

    Case report 07 May 2022 Pages: 30 - 30

31. Amino-acids/electrolytes/lipids-SmofKabiven

    Case report 07 May 2022 Pages: 31 - 31

32. Amiodarone

    Case report 07 May 2022 Pages: 32 - 32

33. Amiodarone/digoxin

    Case report 07 May 2022 Pages: 33 - 33

34. Amiodarone/esmolol/sotalol

    Case report 07 May 2022 Pages: 34 - 34

35. Amiodarone/heparin/rivaroxaban

    Case report 07 May 2022 Pages: 35 - 35

36. Amiodarone/quinine

    Case report 07 May 2022 Pages: 36 - 36

37. Amitriptyline/eletriptan/erenumab

    Case report 07 May 2022 Pages: 37 - 37

38. Amlodipine/isosorbide-mononitrate

    Case report 07 May 2022 Pages: 38 - 38

39. Amoxicillin/clavulanic-acid

    Case report 07 May 2022 Pages: 39 - 39

40. Amoxicillin/clavulanic-acid/clindamycin/vancomycin

    Case report 07 May 2022 Pages: 40 - 40

41. Amphotericin-b-liposomal/voriconazole

    Case report 07 May 2022 Pages: 41 - 41

42. Amphotericin-b/mannitol/steroids

    Case report 07 May 2022 Pages: 42 - 42

43. Amrubicin

    Case report 07 May 2022 Pages: 43 - 43

44. Anastrozole/letrozole/trastuzumab

    Case report 07 May 2022 Pages: 44 - 44

45. Anidulafungin

    Case report 07 May 2022 Pages: 45 - 45

46. Anthracyclines/cytarabine

    Case report 07 May 2022 Pages: 46 - 46

47. Anti-infective drugs

    Case report 07 May 2022 Pages: 47 - 47

48. Anti-inflammatories/Antihypotensives/dobutamine

    Case report 07 May 2022 Pages: 48 - 48

49. Anti-inflammatories/danazol/granulocyte-colony-stimulating-factors

    Case report 07 May 2022 Pages: 49 - 49

50. Anti-inflammatories/unspecified glucocorticoids

    Case report 07 May 2022 Pages: 50 - 50